Jen Lee | Principal Consultant
HEOR Ltd

Day 1 - Tuesday 28 October @ 15:20

Solving the Rare Disease Puzzle Through Thought Partnership

This 15-minute session explores the value of true thought partnership between industry and consultancy in navigating the complex HEOR and market access landscape for rare disease assets. We will define what thought partnership really means, highlight the unique evidence and access challenges in rare diseases, and show how collaborative, strategic engagement can overcome these barriers to deliver meaningful impact for patients and stakeholders.

Miranda Bailey, Health Economics and Outcome Research & Pricing, Rocket Pharmaceuticals, Inc.

×

Miranda Bailey / Solving the Rare Disease Puzzle Through Thought Partnership

Miranda Bailey, Health Economics and Outcome Research & Pricing,
Rocket Pharmaceuticals, Inc.

Miranda Bailey is the Associate Vice President of HEOR & Pricing at Rocket Pharmaceuticals, with over 15 years of experience driving value, access, and health outcomes in rare diseases and gene therapies. She has created and implemented successful global and local market access, HEOR and RWE...

Close

Jen Lee, Principal Consultant, HEOR Ltd

×

Jen Lee / Solving the Rare Disease Puzzle Through Thought Partnership

Jen Lee, Principal Consultant,
HEOR Ltd

Jen Lee is a Principal Consultant at HEOR Ltd with over 13 years’ experience managing global and European HEOR and market access programs for rare disease technologies. She has led UK NICE submissions, overseen complex multi-country reimbursement strategies, and brings expertise in evidence...

Close

Session led by: HEOR